K1Z Stock Overview
A medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Chordate Medical Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0038 |
| 52 Week High | SEK 0.029 |
| 52 Week Low | SEK 0.0001 |
| Beta | 0.81 |
| 11 Month Change | 35.71% |
| 3 Month Change | 3,700.00% |
| 1 Year Change | -86.28% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -91.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| K1Z | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 72.7% | 1.4% | 0.8% |
| 1Y | -86.3% | -1.1% | 2.0% |
Return vs Industry: K1Z underperformed the German Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: K1Z underperformed the German Market which returned 3.1% over the past year.
Price Volatility
| K1Z volatility | |
|---|---|
| K1Z Average Weekly Movement | 1,156.5% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: K1Z's share price has been volatile over the past 3 months.
Volatility Over Time: K1Z's weekly volatility has increased from 955% to 1156% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 3 | Anders Weilandt | www.chordate.com |
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It offers Ozilia, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.
Chordate Medical Holding AB (publ) Fundamentals Summary
| K1Z fundamental statistics | |
|---|---|
| Market cap | €2.70m |
| Earnings (TTM) | -€2.47m |
| Revenue (TTM) | €199.54k |
13.5x
P/S Ratio-1.1x
P/E RatioIs K1Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| K1Z income statement (TTM) | |
|---|---|
| Revenue | SEK 2.27m |
| Cost of Revenue | SEK 472.73k |
| Gross Profit | SEK 1.79m |
| Other Expenses | SEK 29.89m |
| Earnings | -SEK 28.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 79.13% |
| Net Profit Margin | -1,240.25% |
| Debt/Equity Ratio | 0% |
How did K1Z perform over the long term?
See historical performance and comparison